Half-Life of Apixaban
The terminal elimination half-life of apixaban is approximately 12 hours following oral administration. 1
Pharmacokinetic Details
The half-life of apixaban shows some variation based on the formulation and patient population:
- Standard half-life: Approximately 12 hours after oral administration 2, 3, 4, 1
- Range reported in clinical studies: 8 to 14 hours in healthy men 5
- Extended range in some populations: 11 to 26.8 hours following tablet doses ≥5 mg 6
- Consistent findings: Multiple studies confirm approximately 11-12 hours 3, 7, 8
Clinical Implications
Steady-State Achievement
- With a half-life of ~12 hours, apixaban reaches steady-state levels within 3 days when dosed twice daily 2
- The accumulation index is 1.7, consistent with twice-daily dosing and the observed elimination half-life 8
Duration of Anticoagulant Effect
- The pharmacodynamic effect of apixaban can be expected to persist for at least 24 hours after the last dose (approximately two drug half-lives) 1
- This is clinically relevant when considering timing of procedures or managing bleeding complications 1
Dosing Frequency
- The 12-hour half-life supports the twice-daily dosing regimen used in clinical practice without need for anticoagulation monitoring 9
Important Caveats
Age-related variation: The elimination half-life may be slightly prolonged in elderly patients, though this does not typically require dose adjustment based on age alone 4, 1
Renal impairment: While the half-life itself is not dramatically altered, overall drug exposure increases with declining renal function, which is why dose adjustments are recommended in patients with severe renal impairment 4, 1
Formulation differences: Earlier studies with solution formulations showed shorter half-lives (3.6-6.8 hours) compared to tablet formulations, likely due to dissolution-limited absorption characteristics 6